Difference between revisions of "Peruvoside"
From Self-sufficiency
m (Stub sorting and placement of stub template(s)) |
m (1 revision) |
(No difference)
| |
Latest revision as of 08:43, 20 September 2010
| File:Peruvoside.png | |
| Systematic (IUPAC) name | |
|---|---|
|
(3β,5β,8ξ,9ξ)- 3-[(6-deoxy- 3-O-methyl- α-D- glycero- hexopyranosyl)oxy]- 14-hydroxy- 19-oxocard- 20(22)enolide | |
| Identifiers | |
| CAS Number | 1182-87-2 |
| ATC code | C01AX02 (WHO) |
| PubChem | CID 14449 |
| Synonyms | (3S,5R,10R,13R,14S,17R)- 3-[(2S,5R)- 3,5-dihydroxy- 4-methoxy- 6-methyloxan- 2-yl]oxy- 14-hydroxy- 13-methyl- 17-(5-oxo-2H-furan-3-yl)- 1,2,3,4,5,6,7,8,9,11,12,15,16,17- tetradecahydrocyclopenta[a]phenanthrene- 10-carbaldehyde |
| Chemical data | |
| Formula | C30H44O9 |
| Molar mass | 548.665 g/mol[[Script error: No such module "String".]] |
Peruvoside (or cannogenin thevetoside) is a cardiac glycoside[1] for heart failure.[2]
It is derived from Thevetia neriifolia.[2]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Cardenolides
- Alcohols
- Aldehydes
- Cardiovascular system drug stubs
- 2Fix
